Thyrocare Technologies Ltd's Q3FY25 Quarter Results
- 24 Jan 2025
Result Summary
- Thyrocare Technologies Ltd reported a 5.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 23.6%.
- Its expenses for the quarter were down by 0.7% QoQ and up 20.5% YoY.
- The net profit decreased 28.3% QoQ and increased 28.6% YoY.
- The earnings per share (EPS) of Thyrocare Technologies Ltd stood at 3.6 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 169.93 | 179.96 | 137.47 | -5.6% | 23.6% |
Total Expenses | 141.85 | 142.90 | 117.69 | -0.7% | 20.5% |
Profit Before Tax | 28.08 | 37.06 | 19.78 | -24.2% | 42.0% |
Tax | 8.97 | 10.35 | 5.17 | -13.3% | 73.5% |
Profit After Tax | 18.95 | 26.42 | 14.74 | -28.3% | 28.6% |
Earnings Per Share | 3.60 | 5.00 | 2.80 | -28.0% | 28.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Thyrocare Technologies Ltd is a prominent company in the healthcare sector, primarily known for its diagnostic services. The company specializes in biochemical testing and preventive healthcare services. Thyrocare operates a chain of diagnostic and wellness centers across India, offering a wide range of tests and packages to its customers. The firm is well-regarded for its cost-effective diagnostic solutions and extensive network, which helps in catering to a broad customer base. As of the last available information, Thyrocare has been focusing on expanding its operations and improving its service delivery to stay competitive in the rapidly growing healthcare industry.
Revenue
In the third quarter of fiscal year 2025, Thyrocare Technologies Ltd reported a total income of ₹169.93 crores. This marks a decline of 5.6% from the previous quarter, where the total income stood at ₹179.96 crores. However, when compared to the same quarter in the previous fiscal year (Q3FY24), there is a notable increase of 23.6% from ₹137.47 crores. This year-over-year growth indicates that the company has achieved a substantial rise in its revenue over the past year, despite the recent quarter-over-quarter decline.
Profitability
The profitability metrics for Thyrocare Technologies Ltd show a mixed performance. The Profit Before Tax (PBT) for Q3FY25 was ₹28.08 crores, which reflects a decrease of 24.2% from ₹37.06 crores in Q2FY25. On a year-over-year basis, however, the PBT increased by 42.0% from ₹19.78 crores in Q3FY24. After accounting for taxes, the Profit After Tax (PAT) was ₹18.95 crores, down by 28.3% from the previous quarter's ₹26.42 crores, but up by 28.6% from ₹14.74 crores in the same quarter last year. The earnings per share (EPS) followed a similar trend, declining by 28.0% quarter-over-quarter to ₹3.60 but rising by 28.6% year-over-year from ₹2.80.
Operating Metrics
The total expenses for Thyrocare Technologies Ltd in Q3FY25 were ₹141.85 crores, representing a slight decrease of 0.7% from ₹142.90 crores in the previous quarter. In comparison to Q3FY24, total expenses increased by 20.5% from ₹117.69 crores. This increase in expenses year-over-year suggests the company has incurred higher operational costs compared to the same period last year. The tax expenses for the current quarter were ₹8.97 crores, which decreased by 13.3% from ₹10.35 crores in Q2FY25, but increased by 73.5% from ₹5.17 crores in Q3FY24. The fluctuations in tax expenses over the quarters and years reflect changes in the company's tax obligations or tax planning strategies.
